Second, while we have identified two CSC markers including SOX9 and OLFM4 at single‐cell resolution and in vitro experiments, in vivo functional validation in animal models to confirm the role of CSCs in tumor initiation, progression, and resistance is still required. This evidence concerns the gene OLFM4 and neoplasm.